Search

Search Constraints

You searched for: Author/Creator Mortimer, Peter

Search Results

1. 5. Adjuvant taxanes play a key role in the development of upper limb breast cancer-related lymphoedema. Issue 6 (June 2015)

2. 9. Global abnormalities in lymphatic function occur following systemic therapy in breast cancer patients. Issue 6 (June 2015)

3. Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma. (September 2020)

4. Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations). (2021)

6. First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial. (November 2021)

9. PERCEIVED AREAS FOR FUTURE INTERVENTION AND RESEARCH ADDRESSING CONVEYANCE DECISIONS AND POTENTIAL THREATS TO PATIENT SAFETY: STAKEHOLDER WORKSHOPS. Issue 9 (18th August 2016)

10. Redefining WILD syndrome: a primary lymphatic dysplasia with congenital multisegmental lymphoedema, cutaneous lymphovascular malformation, CD4 lymphopaenia and warts. Issue 1 (16th December 2021)